BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zeng S, Wang H, Chen Z, Cao Q, Hu L, Wu Y. Effects of geranylgeranylacetone upon cardiovascular diseases. Cardiovasc Ther 2018;36:e12331. [DOI: 10.1111/1755-5922.12331] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Xie Y, Chen L, Xu Z, Li C, Ni Y, Hou M, Chen L, Chang H, Yang Y, Wang H, He R, Chen R, Qian L, Luo Y, Zhang Y, Li N, Zhu Y, Ji M, Liu Y. Predictive Modeling of MAFLD Based on Hsp90α and the Therapeutic Application of Teprenone in a Diet-Induced Mouse Model. Front Endocrinol (Lausanne) 2021;12:743202. [PMID: 34659125 DOI: 10.3389/fendo.2021.743202] [Reference Citation Analysis]
2 Gong Y, Huang X, Chen M, Xiong L. Teprenone improves gastric mucosal injury and dyspeptic symptoms in long-term nonsteroidal anti-inflammatory drug users. J Gastroenterol Hepatol 2019;34:1344-50. [PMID: 30681185 DOI: 10.1111/jgh.14614] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
3 Esmaeili Z, Niaz Q, Saffari PM, Dehpour AR, Rezayat SM, Jazaeri F. Evaluation of the effect of heat shock protein 70 targeted drugs on cirrhotic cardiomyopathy in biliary cirrhotic rats. Life Sci 2021;273:119261. [PMID: 33652036 DOI: 10.1016/j.lfs.2021.119261] [Reference Citation Analysis]